Category: Synthetic drugs

Synthetic drugs

K2 explosion: What happened in Connecticut?

September 6, 2018 By

K2 is not a safe alternative to marijuana. On the contrary, its dangerous chemicals are mostly unknown and carry a high risk of drug overdose.

Synthetic drugs

Synthetic cannabinoid overdoses spike

August 16, 2016 By

The number of cases of poisoning from synthetic marijuana rose sharply in the past year.

Synthetic drugs

Refining our synthetic cannabinoids panel

April 18, 2016 By

Our experts continually monitor and adjust our drug tests to offer a standardized panel that detects the most relevant synthetic cannabinoids.

Synthetic drugs

The DEA crackdown on synthetic drugs

November 4, 2015 By

With growing public concern in mind, the DEA launched a 15 month counteractive campaign to combat the manufacturing and distribution of designer drugs

Synthetic drugs

Name that Drug: A stimulating psychoactive perspective

September 15, 2015 By

DATIA focus features a regular column titled, “Name that Drug” where interesting facts about a mystery drug are described.

Synthetic drugs

Synthetic drugs: Common questions

July 24, 2015 By

Dr. Kim Samano presented information about synthetic cannabinoids ("K2/Spice") and designer stimulants known as “bath salts” in our recent webinar.

Synthetic drugs

Synthetic drugs: What you need to know

June 22, 2015 By

Our webinar will provide an overview of synthetic drugs, review trends in usage and patterns and discuss the challenges for a workplace program.

Synthetic drugs

Synthetic marijuana: Catch me if you can

June 9, 2015 By

Difficult to detect and harmful if consumed, designer drugs are infiltrating society, leaving unequivocal damage in their wake.

Synthetic drugs

Changing perceptions of marijuana and synthetic marijuana

March 5, 2015 By

High school seniors' perceived risk with occasional marijuana use is declining while they increasingly view synthetic marijuana use as harmful.

Synthetic drugs

More synthetic cannabinoids elevated to Schedule I ban

February 13, 2015 By

The Drug and Alcohol Testing Administration details the addition of three synthetic cannabinoids to the Schedule I category by the DEA.